InvestmentJun 12, 2026, 10:01 PM
Arcadia Biosciences Closes $4M Private Placement
AI Summary
Arcadia Biosciences, Inc. announced the closing of its previously announced private placement, generating approximately $4 million in gross proceeds. The offering included the sale of 3,883,496 shares of common stock (or pre-funded warrants) and associated Series A-1 and Series A-2 preferred investment options at a purchase price of $1.03 per share. The net proceeds from this financing will be allocated towards working capital and general corporate purposes.
Key Highlights
- Arcadia Biosciences closed a private placement, raising approximately $4 million in gross proceeds.
- The offering included 3,883,496 shares of common stock or pre-funded warrants.
- Series A-1 and Series A-2 preferred investment options were also part of the offering.
- The purchase price was $1.03 per share of common stock or pre-funded warrant.
- Both Series A-1 and A-2 preferred investment options have an exercise price of $0.91 per share.
- Net proceeds from the offering will be used for working capital and general corporate purposes.
Price Impact
More from RKDA